Solute carriers as drug targets: current use, clinical trials and prospective.
about
Mitochondrial Glutathione in Diabetic NephropathySLC transporters as therapeutic targets: emerging opportunitiesRole of solute carriers in response to anticancer drugsHost Delivery of Favorite Meals for Intracellular PathogensComputational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.Putative Membrane-Bound Transporters MFSD14A and MFSD14B Are Neuronal and Affected by Nutrient Availability.Glucose transport machinery reconstituted in cell models.Synthesis and optical behaviors of 6-seleno-deoxyguanosinePlacental transporter localization and expression in the Human: the importance of species, sex, and gestational age differences†.Maternal Early Pregnancy Serum Metabolites and Risk of Gestational Diabetes Mellitus.Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.Efflux proteins at the blood-brain barrier: review and bioinformatics analysis.Recent advances in nanodisc technology for membrane protein studies (2012-2017).Radioligand binding to nanodisc-reconstituted membrane transporters assessed by the scintillation proximity assayCharacteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression.Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics.Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.Structural prediction of two novel human atypical SLC transporters, MFSD4A and MFSD9, and their neuroanatomical distribution in mice.Comprehensive analysis of gene expression patterns in Friedreich's ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers.Glucose Transport Activity Measured in Giant Vesicles.Cell Membrane Transport Mechanisms: Ion Channels and Electrical Properties of Cell Membranes.The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma.Insights into Transporter Classifications: an Outline of Transporters as Drug Targets
P2860
Q26799424-5F1E1E6A-6F07-4F9C-B9D0-9F7B1B0FA490Q27014726-09F617AB-CC23-44B0-84AC-B05B58CA57B4Q27027625-374D0742-321A-451F-8D35-756CFD365FE1Q28087165-D74E6629-305F-4A6B-A793-61816337030DQ34155176-2FB8BA30-13BD-497C-8AC6-A0551E2261B4Q34550857-0F596AA0-C216-4B16-90AD-05853FF1F461Q35019740-61412F5A-F135-4F4E-B5B4-E1E2521699CCQ36089223-E29C4283-139A-41BB-B837-7F8185639E23Q36322293-AF5F5E07-FC82-4645-A3CE-66DBC09B436BQ36433587-0B1976F7-8228-4210-923C-BE473A43E5C3Q36939981-F8FCDD17-F5FE-4857-AC9C-67E5857B21C3Q38243334-90697BD6-04CD-4721-B408-BDD817E77EFCQ38708393-C0FFD60C-D09B-4E80-B853-AF2B4FC229FAQ39290800-138D918A-9FB7-4FE9-97DC-68D1494A51EAQ39350771-474D1ED2-5220-494A-8A0A-D04809F6389FQ40847376-11ED162A-A038-4CED-ACC1-E241D78B4284Q41981224-B0417802-E4E3-4D0C-821B-D027106DDD55Q42873690-2B932F0E-90D7-4C4C-B400-786998767D16Q43088347-332FDD1C-9369-4D5E-A6D8-CA27C544D9BDQ43289356-D6458751-6E40-4887-88E6-BAAEF1290263Q47104232-84921B0E-2A16-462F-92DA-E22211912D48Q47316702-804312CE-2BF0-4125-9E72-DD5720E2C08CQ49589400-9A5D0D24-09AB-41C9-9183-F7DB791871AEQ54988096-47188B14-4DE4-438C-A2E9-7772273A25E6Q55030406-35149E35-9DD7-40F2-9969-A83EB377B237Q56980193-DA3C26DA-18B9-443B-91EB-C686EA54533D
P2860
Solute carriers as drug targets: current use, clinical trials and prospective.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Solute carriers as drug targets: current use, clinical trials and prospective.
@ast
Solute carriers as drug targets: current use, clinical trials and prospective.
@en
Solute carriers as drug targets: current use, clinical trials and prospective.
@nl
type
label
Solute carriers as drug targets: current use, clinical trials and prospective.
@ast
Solute carriers as drug targets: current use, clinical trials and prospective.
@en
Solute carriers as drug targets: current use, clinical trials and prospective.
@nl
prefLabel
Solute carriers as drug targets: current use, clinical trials and prospective.
@ast
Solute carriers as drug targets: current use, clinical trials and prospective.
@en
Solute carriers as drug targets: current use, clinical trials and prospective.
@nl
P1476
Solute carriers as drug targets: current use, clinical trials and prospective
@en
P2093
Helgi B Schiöth
Surendar Masuram
P304
P356
10.1016/J.MAM.2012.07.015
P577
2013-04-01T00:00:00Z